Glucagonoma syndrome
Glucagonoma syndrome, also known as necrolytic migratory erythema, is a syndrome characterized by recurrent necrolytic migratory erythema, stomatitis, weight loss, and diabetes, often accompanied by pancreatic cell tumors that secrete glucagon. About 80% of tumors are malignant, and half may metastasize. Skin lesions often appear several years before tumors. The cause is still unclear, but it is speculated to be related to hypersecretion of glucagon.
-
Site of disease:
Skin mouth pancreas -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Increased blood sugar diabetes hypoproteinemia hypokalemia rash -
Concurrent disease:
Related Drugs
Phenformin Hydrochloride Tablets
Indication: It is used for patients with type 2 diabetes who are not satisfied with diet control alone, especially those who are obese and have hyperinsulinemia. This drug not only has the effect of lowering blood sugar, but also has the effect of reducing weight and hyperinsulinemia. It can be effective for patients with poor response to certain sulfonylureas. For example, it is more effective when used in combination with sulfonylurea hypoglycemic drugs, intestinal glycosidase inhibitors or thiazolidinedione hypoglycemic drugs than when used alone. It can also be used for patients treated with insulin to reduce the amount of insulin used.
Related Ingredients